Five things for pharma marketers to know: Thursday, June 1, 2023

Five things for pharma marketers to know

• RA Capital-backed Summation Bio is “terminating operations” next month, per an employee’s LinkedIn profile update.

• Abbott sued a former scientist over alleged trade-secret theft – in particular “secretly downloading” competitive information on nutrition products.
• The Food and Drug Administration put a clinical hold on PepGen’s investigational new drug application for its myotonic dystrophy type 1 drug, PGN-EDODM1, with the agency to provide further details within a month.

• The Sackler family will be protected from current and future lawsuits over their role in their Purdue Pharma’s opioid business, a New York court of appeals ruled.
• Former First Lady Rosalynn Carter has been diagnosed with dementia at age 95.